Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Rothenfusser

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Experimental Medicine|July 18, 2020
Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19Lars M Koenig, Daniel F R Boehmer, Philipp Metzger, et al.
European Journal of Immunology|June 5, 2003
Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cellsGunther Hartmann, Julia Battiany, Hendrik Poeck, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2004
Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virusVeit Hornung, Jörg Schlender, Margit Guenthner-Biller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotidesVeit Hornung, Simon Rothenfusser, Stefanie Britsch, et al.
Cancer Research|April 17, 2002
Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cellsMax Schnurr, Christoph Scholz, Simon Rothenfusser, et al.
Nanomaterials (Basel, Switzerland)|March 29, 2017
Cellular Uptake of Tile-Assembled DNA NanotubesSamet Kocabey, Hanna Meinl, Iain S MacPherson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursorsMarc Dauer, Bianca Obermaier, Jan Herten, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2003
Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cellsMiren Kerkmann, Simon Rothenfusser, Veit Hornung, et al.
European Journal of Immunology|January 31, 2003
Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapyKlaus Heckelsmiller, Sebastian Beck, Katharina Rall, et al.
Viruses|February 26, 2022
High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon ParticlesArlen-Celina Lücke, Anja Vom Hemdt, Janett Wieseler, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Experimental Medicine|July 18, 2020
Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19Lars M Koenig, Daniel F R Boehmer, Philipp Metzger, et al.
European Journal of Immunology|June 5, 2003
Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cellsGunther Hartmann, Julia Battiany, Hendrik Poeck, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2004
Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virusVeit Hornung, Jörg Schlender, Margit Guenthner-Biller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotidesVeit Hornung, Simon Rothenfusser, Stefanie Britsch, et al.
Cancer Research|April 17, 2002
Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cellsMax Schnurr, Christoph Scholz, Simon Rothenfusser, et al.
Nanomaterials (Basel, Switzerland)|March 29, 2017
Cellular Uptake of Tile-Assembled DNA NanotubesSamet Kocabey, Hanna Meinl, Iain S MacPherson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursorsMarc Dauer, Bianca Obermaier, Jan Herten, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2003
Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cellsMiren Kerkmann, Simon Rothenfusser, Veit Hornung, et al.
European Journal of Immunology|January 31, 2003
Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapyKlaus Heckelsmiller, Sebastian Beck, Katharina Rall, et al.
Viruses|February 26, 2022
High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon ParticlesArlen-Celina Lücke, Anja Vom Hemdt, Janett Wieseler, et al.
Pageof 7